ORIGINAL ARTICLE

JOP. J Pancreas (Online) 2004; 5(3):132-137.

Assessment of Platelet Adhesiveness and Aggregation in Mild Acute Pancreatitis Using the PFA-100TM System

Konstantinos Mimidis1, Vassilios Papadopoulos1, Zafiris Kartasis2, Maria Baka2, Vassilios Tsatlidis1, Georgios Bourikas2, Georgios Kartalis1

1First Department of Internal Medicine and 2Department of Hematology, Democritus University of Thrace Medical School. Alexandroupolis, Greece

ABSTRACT

Context Acute pancreatitis constitutes a systemic inflammatory process which is often accompanied by thrombosis and bleeding disorders. The role of platelets in the pathophysiology of the disease remains to be elucidated.

Objective In the present study, we evaluated the alterations of platelet function in patients suffering from acute edematous pancreatitis using the recently developed platelet function analyzer PFA-100TM.

Design A cohort study with one end-point (difference between patients with acute edematous pancreatitis and normal controls concerning at least one PFA-100TM closure time at the P<0.01 level of statistical significance).

Main outcome measure The hemostatic capacity of platelets was tested in citrated blood and standard cartridges containing collagen-ADP or collagen-epinephrine.

Patients We studied 16 patients (6 women and 10 men, mean age 62.1 years) with acute edematous pancreatitis, who had been admitted to our Internal Medicine Department, along with 32 normal controls of similar age and having the same woman-man ratio.

Results The mean closure time using collagen-ADP cartridges was 69.6 s (95% CI: 60.4-78.7 s) in patients and 96.1 s (95% CI: 93.0-99.3 s) in normal controls (t-value: 7.2; P<0.001). The mean closure time using collagen-epinephrine cartridges was 110.7 s (95% CI: 100.1-121.3 s) in patients and 119.7 s (95% CI: 114.6-124.8 s) in normal controls (t-value: 1.8; P=0.078). The hematocrit in all patients was less than the upper reference value.

Conclusions The PFA-100TM represents a simple and easy to use test for investigating primary hemostasis. Although the method has been widely used in hemorrhagic conditions, this is the first time it has been applied in the prethrombotic model of acute pancreatitis, suggesting increased platelet adhesiveness and aggregation.

Full text:   HTML format   PDF format
  Original data and statistics
  Look up who cited this article
Comment in:  JOP. J Pancreas (Online) 2004; 5(4):237-238.
Authors' Reply:  JOP. J Pancreas (Online) 2004; 5(4):238-239.

References

  1. Kerekes L, Arkossy P, Altorjay I, Huszka M, Kappelmayer J, Toth P, et al. Evaluation of hemostatic changes and blood antioxidant capacity in acute and chronic pancreatitis. Hepatogastroenterology 2001;48:1746-9. [More details]

  2. Lukaszyk A, Bodzenta-Lukaszyk A, Gabryelewicz A, Bielawiec M. Does acute experimental pancreatitis affect blood platelet function? Thromb Res 1989;53:319-25. [More details]

  3. Musselman DL, Marzec UM, Manatunga A, Penna S, Reemsnyder A, Knight BT, et al. Platelet reactivity in depressed patients treated with paroxetine. Arch Gen Psychiatry 2000;57:875-82. [More details]

  4. Collins CE, Cahill MR, Newland AC, Rampton DS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994;106:840-5. [More details]

  5. Danese S, de la Motte C, Sturm A, Vogel JD, West GA, Strong SA, et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003;124:1249-64. [More details]

  6. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroumbakis IE, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001;96:776-81. [More details]

  7. Mimidis K, Papadopoulos V, Kotsianidis J, Filippou D, Spanoudakis E, Bourikas G, et al. Alterations of platelet function, number and indexes during acute pancreatitis. Pancreatology 2004;4:22-7. [More details]

  8. Michelson AD, Furman MI. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol 1999;6:342-8. [More details]

  9. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost 1995;21:106-12. [More details]

  10. Wuillemin WA, Gasser KM, Zeerleder SS, Lämmle B. Evaluation of a Platelet Function Analyser (PFA-100®) in patients with a bleeding tendency. Swiss Med Wkly 2002;132:443-8. [More details]

  11. Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002;13:301-6. [More details]

  12. Ault KA. The clinical utility of flow cytometry in the study of platelets. Semin Hematol 2001;38:160-8. [More details]

  13. Gosselin RC, Paglieroni T, Owings J, Utter G, Jacoby R, Larkin EC. Decreased PFA-100 values is associated with increased platelet activation. In: 7th Annual Meeting of the European Hematology Association. Florence, Italy, 6-9 June 2002. Bologna, Italy: Monduzzi Editore, International Proceedings Division, 2002. [More details]

  14. Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, et al. A new method of assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195-202. [More details]

  15. Escolar G, Cases A, Vinas M, Pino M, Calls J, Cirera I, et al. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100TM): influence of hematocrit elevation. Haematologica 1999;84:614-9. [More details]

Keywords Hemostasis; Microcirculation; Platelet Function Tests; Pancreatitis

Correspondence Konstantinos Mimidis: kmimidis@otenet.gr